Milestone PharmaceuticalsMIST
那斯達克 · USD
1.87
+0.07
(+3.89%)
收盤 05/02 03:59 (UTC+8)
05/02 03:59 (UTC+8)
Milestone PharmaceuticalsMIST
1.87
+0.07
(+3.89%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 1,546 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,546 | - | - | - | - | - | - | - | - | - |
營業費用 | 18,803 | 11,829 | 12,531 | 20,523 | 12,348 | 9,616 | 9,662 | 10,476 | 13,800 | 15,360 |
研發費用 | 5,521 | 3,940 | 3,669 | 4,978 | 3,940 | 3,963 | 2,815 | 3,639 | 5,452 | 6,721 |
推銷及管理費用 | 13,282 | 7,889 | 8,862 | 15,545 | 8,408 | 5,653 | 6,847 | 6,837 | 8,348 | 8,639 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -17,257 | -11,829 | -12,531 | -20,523 | -12,348 | -9,616 | -9,662 | -10,476 | -13,800 | -15,360 |
其他收入及費用 | 833 | 874 | 516 | 697 | 904 | 1,080 | 1,186 | 994 | 1,046 | 1,120 |
利息費用 | 985 | 967 | 951 | 935 | 919 | 903 | 887 | 872 | 857 | 841 |
稅前純益 | -17,409 | -11,922 | -12,966 | -20,761 | -12,363 | -9,439 | -9,363 | -10,354 | -13,611 | -15,081 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -17,409 | -11,922 | -12,966 | -20,761 | -12,363 | -9,439 | -9,363 | -10,354 | -13,611 | -15,081 |
基本每股稅後盈餘(元) | -0.12 | -0.12 | -0.20 | -0.31 | -0.18 | -0.14 | -0.14 | -0.21 | - | -0.35 |
稀釋每股稅後盈餘(元) | -0.15 | -0.12 | -0.20 | -0.31 | -0.19 | -0.14 | -0.13 | -0.21 | -0.32 | -0.35 |
基本平均股數(千股) | - | 96494.00 | 66380.00 | 66285.00 | - | 66190.00 | 66165.00 | 50155.00 | - | 42973.00 |
稀釋平均股數(千股) | - | 96494.00 | 66380.00 | 66285.00 | - | 66190.00 | 66165.00 | 50155.00 | - | 42973.00 |
還原基本每股稅後盈餘(元) | -0.12 | -0.12 | -0.20 | -0.31 | -0.18 | -0.14 | -0.14 | -0.21 | - | -0.35 |
還原稀釋每股稅後盈餘(元) | -0.15 | -0.12 | -0.20 | -0.31 | -0.19 | -0.14 | -0.13 | -0.21 | -0.32 | -0.35 |
還原基本平均股數(千股) | - | 96,494 | 66,380 | 66,285 | - | 66,190 | 66,165 | 50,155 | - | 42,973 |
還原稀釋平均股數(千股) | - | 96,494 | 66,380 | 66,285 | - | 66,190 | 66,165 | 50,155 | - | 42,973 |
EBITDA(千元) | -16,275 | -10,821 | -11,881 | -19,778 | -11,438 | -8,530 | -8,489 | -9,460 | -12,727 | -14,164 |